Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 9Uterine Cervical Neoplasms 5Vaginal Neoplasms 2Radiation Injuries 2Endometrial Neoplasms 2Breast Neoplasms 2Sarcoma 1Rhabdomyosarcoma 1Retinoblastoma 1Prostatic Diseases 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neuroectodermal Tumors, Primitive, Peripheral 1Metastatic Malignant Female Reproductive System Neoplasm 1Gynecologic Cancer 1Desmoplastic Small Round Cell Tumor 1Carcinosarcoma 1Carcinoma, Ductal 1

Interventions

gallium 68 PSMA-11 1Robotic Surgical Procedures 1Radiotherapy 1Nivolumab 1Brachytherapy 1Androgen Antagonists 1(225)Ac-PSMA-617 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Prostatic Diseases × Brachytherapy × Clear all
NCT03543189 2026-04-01

Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy

H. Lee Moffitt Cancer Center and Research Institute

Phase 1/2 Active not recruiting
44 enrolled
Genitourinary

Prostatic Diseases, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡